Shaanxi Micot Pharmaceutical Technology Co., Ltd.

This study tested a new drug called MT1013 in 98 adults on kidney dialysis who have secondary hyperparathyroidism, a condition where parathyroid glands become overactive. The goal was to see if the drug safely lowers parathyroid hormone levels. Participants received either the dr…